Mortality in severe asthma: results from the NORDSTAR cohort
European Respiratory Journal · 2026
DOI: 10.1183/13993003.01289-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Susanne Hansen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark susanne.hansen.10@regionh.dk. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: GlaxoSmithKline, AstraZeneca, Sanofi.
Abstract (Originalsprache)
Background
Longitudinal data addressing the impact of asthma severity on mortality are lacking. We aimed to explore all-cause and cause-specific mortality according to asthma severity.
Methods
The present registry-based cohort study is based on Danish data from the NORdic Dataset for aSThmA Research (NORDSTAR) research collaboration platform. Adult patients with severe asthma were matched on age and sex to 10 patients with mild-to-moderate asthma and followed from 2000 to 2020. Patients with COPD diagnosed prior to inclusion were excluded. Absolute and relative measures of all-cause and cause-specific mortality were compared between severe and mild-to-moderate asthma.
Results
We included 11 881 and 118 810 patients with severe and mild-to-moderate asthma, respectively. All-cause mortality was significantly higher in patients with severe asthma compared to patients with mild-to-moderate asthma, both in absolute measures of the cumulative mortality (34% (95% CI 32–35%) versus 20% (95% CI 19–20%); p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark susanne.hansen.10@regionh.dk.
- Centre for Clinical Research and Prevention, Frederiksberg Hospital, Copenhagen, Denmark.
- Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark.
- Quantify Research, Stockholm, Sweden.
- Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden.
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
ORCID-Profile: Susanne Hansen, Anna von Bülow, Olivia Ernstsson, Christer Janson, Lauri Lehtimäki, Josephine Hjoberg, Alan Altraja, Helena Backman, Vibeke Backer, Valentyna Yasinska, Charlotte Suppli Ulrik, Apostolos Bossios
Förderung
- GlaxoSmithKline
- AstraZeneca
- Sanofi
Zitieren
APA
Hansen, S., von Bülow, A., Cooper, A., Sandin, P., Ernstsson, O., Kankaanranta, H., Janson, C., Lehtimäki, L., Aarli, B. B., Geale, K., Hjoberg, J., Packham, S., Sekulic, D., Altraja, A., Backman, H., Karjalainen, J., Sverrild, A., Backer, V., Kauppi, P., …, & Bossios, A. (2026). Mortality in severe asthma: results from the NORDSTAR cohort. European Respiratory Journal. https://doi.org/10.1183/13993003.01289-2025
Vancouver
Hansen S, von Bülow A, Cooper A, Sandin P, Ernstsson O, Kankaanranta H, et al. Mortality in severe asthma: results from the NORDSTAR cohort. European Respiratory Journal. 2026. doi:10.1183/13993003.01289-2025
BibTeX
@article{Hansen2026,
author = {Hansen, Susanne and von Bülow, Anna and Cooper, Alexandra and Sandin, Patrik and Ernstsson, Olivia and Kankaanranta, Hannu and Janson, Christer and Lehtimäki, Lauri and Aarli, Bernt Bøgvald and Geale, Kirk and Hjoberg, Josephine and Packham, Sylvia and Sekulic, Davorka and Altraja, Alan and Backman, Helena and Karjalainen, Jussi and Sverrild, Asger and Backer, Vibeke and Kauppi, Paula and Yasinska, Valentyna and Porsbjerg, Celeste and Ulrik, Charlotte Suppli and Bossios, Apostolos},
title = {Mortality in severe asthma: results from the NORDSTAR cohort},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.01289-2025}
}
EUVIMED